Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
38.97
-0.10 (-0.26%)
At close: Mar 9, 2026, 4:00 PM EDT
39.55
+0.58 (1.49%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Vera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -299.62 | -152.15 | -95.99 | -89.06 | -32.61 | |
| Depreciation & Amortization | 0.47 | 0.11 | 0.02 | -0.85 | 0.18 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | -2.69 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | -1 | |
| Loss (Gain) From Sale of Investments | -6.98 | -8.97 | -4.43 | 0.81 | 0.89 | |
| Stock-Based Compensation | 37.93 | 20.8 | 11.49 | 8.89 | 3.01 | |
| Other Operating Activities | 4.11 | 2.87 | 2.55 | 5.86 | 5 | |
| Change in Accounts Payable | 13.91 | -3.45 | -0.87 | 10.61 | 0.48 | |
| Change in Other Net Operating Assets | 9.08 | 6.11 | -4.95 | -3.86 | 3.04 | |
| Operating Cash Flow | -241.1 | -134.68 | -92.18 | -67.6 | -23.71 | |
| Capital Expenditures | -0.63 | -0.97 | -0.06 | -0.06 | - | |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.8 | |
| Sale (Purchase) of Intangibles | - | - | - | - | -5 | |
| Investment in Securities | 195.72 | -424.06 | -39.37 | -70.49 | - | |
| Other Investing Activities | -0.8 | - | - | - | - | |
| Investing Cash Flow | 194.29 | -425.03 | -39.43 | -70.55 | -4.2 | |
| Long-Term Debt Issued | 23.34 | - | 24.74 | 19.82 | 4.92 | |
| Total Debt Issued | 23.34 | - | 24.74 | 19.82 | 4.92 | |
| Net Debt Issued (Repaid) | 23.34 | - | 24.74 | 19.82 | 4.92 | |
| Issuance of Common Stock | 306.98 | 645.91 | 116.06 | 88.21 | 51.73 | |
| Repurchase of Common Stock | - | -0.01 | - | - | - | |
| Other Financing Activities | -21.42 | -39.23 | -7.26 | -6.1 | -2.77 | |
| Financing Cash Flow | 308.9 | 606.67 | 133.54 | 101.93 | 53.88 | |
| Net Cash Flow | 262.08 | 46.97 | 1.93 | -36.22 | 25.97 | |
| Free Cash Flow | -241.73 | -135.65 | -92.24 | -67.66 | -23.71 | |
| Free Cash Flow Per Share | -3.76 | -2.45 | -2.16 | -2.55 | -1.76 | |
| Cash Interest Paid | 6.72 | 6.65 | 3.35 | 0.9 | 0.02 | |
| Levered Free Cash Flow | -139.02 | -84.35 | -58.02 | -42.37 | -20.38 | |
| Unlevered Free Cash Flow | -134.32 | -79.58 | -55.66 | -41.75 | -20.37 | |
| Change in Working Capital | 22.99 | 2.66 | -5.82 | 6.75 | 3.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.